These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28693795)

  • 1. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis.
    Dolan RD; McSorley ST; Horgan PG; Laird B; McMillan DC
    Crit Rev Oncol Hematol; 2017 Aug; 116():134-146. PubMed ID: 28693795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.
    Dolan RD; Lim J; McSorley ST; Horgan PG; McMillan DC
    Sci Rep; 2017 Dec; 7(1):16717. PubMed ID: 29196718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review.
    Dolan RD; Laird BJA; Horgan PG; McMillan DC
    Crit Rev Oncol Hematol; 2018 Dec; 132():130-137. PubMed ID: 30447918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
    Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
    Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of pre-operative inflammatory markers in resected gallbladder cancer: a systematic review.
    Saqib R; Pathak S; Smart N; Nunes Q; Rees J; Finch Jones M; Poston G
    ANZ J Surg; 2018 Jun; 88(6):554-559. PubMed ID: 29205753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and cancer: What a surgical oncologist should know.
    Dupré A; Malik HZ
    Eur J Surg Oncol; 2018 May; 44(5):566-570. PubMed ID: 29530345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of the Prognostic Role of Hematologic Scoring Systems in Patients With Renal Cell Carcinoma Undergoing Nephrectomy With Curative Intent.
    Grimes N; Tyson M; Hannan C; Mulholland C
    Clin Genitourin Cancer; 2016 Aug; 14(4):271-6. PubMed ID: 26949171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.
    Lucca I; de Martino M; Hofbauer SL; Zamani N; Shariat SF; Klatte T
    World J Urol; 2015 Dec; 33(12):2045-52. PubMed ID: 25894368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer.
    Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K
    Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
    Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X
    Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
    Guthrie GJ; Charles KA; Roxburgh CS; Horgan PG; McMillan DC; Clarke SJ
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):218-30. PubMed ID: 23602134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
    Qi Q; Geng Y; Sun M; Wang P; Chen Z
    Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis.
    Kim MR; Kim AS; Choi HI; Jung JH; Park JY; Ko HJ
    PLoS One; 2020; 15(7):e0236445. PubMed ID: 32716955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of systemic inflammatory response markers in urological malignancy.
    Ohno Y
    Int J Urol; 2019 Jan; 26(1):31-47. PubMed ID: 30253448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
    Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.